Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Discovery of a glucagon receptor antagonist for the treatment of diabetes

Jan. 3, 2005

Swedish approval for Tostrex

Jan. 3, 2005

Ligand and TAP extend research collaboration

Jan. 3, 2005

Synthesis and preclinical efficacy of YM-75440, a novel, orally active squalene synthase inhibitor

Dec. 30, 2004

U.S. phase IIb results for Technosphere Insulin, phase III begins in Europe

Dec. 30, 2004

BioMarin begins phase II trial of Phenoptin for PKU

Dec. 30, 2004

Protein tyrosine phosphatase-1B inhibitors for diabetes

Dec. 29, 2004

PPAR modulators disclosed in a patent

Dec. 29, 2004

Sankyo team isolates antidiabetic compound from a natural source

Dec. 29, 2004

Sustained anorectic effect of the CB1 receptor antagonist, AM-251, shown in rats

Dec. 29, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 22, 2026.
‘Detargeted’ targeted gene therapy improves activity in Pompe
BioWorld
A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
Genescience presents STAT6 degrader for atopic dermatitis
BioWorld Science
Genescience Pharmaceutical Co. Ltd. has presented data on a new STAT6 PROTAC degrader – GenSciP166 – which selectively targets STAT6 for proteasomal degradation....
Roche reports new TREM2 agonists
BioWorld Science
F. Hoffmann-la Roche Ltd. and Hoffmann-La Roche Inc. have identified new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for...